Target intelligence / Profile preview

Neurobeachin pseudogene 6 (NBEAP6)

Target: NBEAP6
Molecular classification: Other (Pseudogene)

Overview

Neurobeachin pseudogene 6 (NBEAP6) is annotated as a pseudogene in the human genome, predicted based on homology to the functional neurobeachin (NBEA) gene[4]. Unlike NBEA, which encodes a large, brain-enriched scaffolding protein involved in synaptic targeting and is associated with neurological and metabolic disorders[2][3], NBEAP6 does not produce a functional protein and is not considered a molecular target. There is no evidence for therapeutic relevance, molecular activity, or disease association of NBEAP6. The annotation as a pseudogene indicates that information on receptors, molecular family, biological function, and drug targeting are not applicable.

Other names: Neurobeachin pseudogene 6NBEAP6

Beyond the preview

Go deeper on Neurobeachin pseudogene 6 (NBEAP6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurobeachin pseudogene 6 (NBEAP6).

Explore the full profile